49 results on '"Chiarelli, Giuseppe"'
Search Results
2. The impact of cannabis use disorder on urologic oncologic surgery morbidity, length of stay, and inpatient cost: analysis of the National Inpatient Sample from 2003 to 2014
3. The Impact of Radical Prostatectomy Versus Radiation Therapy on Cancer-Specific Mortality for Nonmetastatic Prostate Cancer: Analysis of an Other-Cause Mortality Matched Cohort
4. Admission Rates, Healthcare Utilization, and Inpatient Cost of Radiation Cystitis in the United States
5. Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort
6. Race has no impact on prostate cancer–specific mortality, when comparing patients with similar risk of other‐cause mortality: An analysis of a population‐based cohort.
7. MP19-03 TESTING FREE PSA PERCENTAGE AS A TOOL IN PREDICTING FUTURE RISK OF DEVELOPING PROSTATE CANCER: A SYSTEM WIDE ANALYSIS OF A CONTEMPORARY NORTH AMERICAN COHORT
8. MP68-03 RACE HAS NO IMPACT ON PROSTATE CANCER-SPECIFIC MORTALITY, WHEN COMPARING PATIENT WITH SIMILAR OVERALL HEALTH STATUS: AN ANALYSIS OF POPULATION-BASED COHORT
9. MP19-02 MIDLIFE BASELINE PSA AS A PREDICTOR OF LETHAL PROSTATE CANCER: RACIAL DIFFERENCES BETWEEN BLACK AND WHITE MEN
10. PD45-07 EXTERNAL VALIDATION OF THE AMSTERDAM-BRISBANE-SYDNEY NOMOGRAM FOR THE PREDICTION OF LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS SUBJECTED TO RADICAL PROSTATECTOMY AND CONCOMITANT LYMPH NODE DISSECTION
11. PD19-12 THE ROLE OF PSMA PET/CT IN PREDICTING PATHOLOGICAL LOCAL STAGING AND GRADING FOR PROSTATE CANCER
12. MP74-03 SUPERIORITY OF MIDLIFE BASELINE PROSTATE-SPECIFIC ANTIGEN VALUE OVER PSA DOUBLING TIME AND VELOCITY IN THE PREDICTION OF LETHAL PROSTATE CANCER DEVELOPMENT, AND MORTALITY: A SYSTEM WIDE ANALYSIS OF A RACIALLY DIVERSE NORTH AMERICAN COHORT
13. MP68-02 ASSOCIATION OF AREA OF DEPRIVATION INDEX WITH PROSTATE CANCER INCIDENCE AND LETHALITY OVER A CONTEMPORARY NORTH AMERICAN COHORT
14. PD50-02 DIFFERENTIAL IMPACT OF PROSTATE-SPECIFIC ANTIGEN SCREENING PATTERN ON PROSTATE CANCER-MORTALITY AMONG NON-HISPANIC BLACK AND NON-HISPANIC WHITE MEN: A LARGE, URBAN HEALTH SYSTEM COHORT ANALYSIS
15. PD13-04 ACTIVE SURVEILLANCE FOR PROSTATE CANCER IN “REAL-WORLD” SETTING: EXPLORING RACIAL DISPARITIES IN SURVEILLANCE INTENSITY AND CANCER CONTROL OUTCOMES
16. PD18-09 THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY IN CONTEMPORARY METASTATIC RENAL CELL CARCINOMA: AN OTHER-CAUSE MORTALITY MATCH POPULATION-BASED STUDY
17. MP49-04 IS MULTIPARAMETRIC MRI ALWAYS NEEDED IN BIOPSY-NAÏVE PATIENTS WITH ABNORMAL DIGITAL RECTAL EXAMINATION? A SINGLE-INSTITUTIONAL EXPERIENCE COMBINING CLINICAL AND MICRO-ULTRASONOGRAPHY BASED FACTORS TO OPTIMIZE PROSTATE CANCER DETECTION
18. PD29-08 ASSOCIATION OF AREA DEPRIVATION INDEX AND RACE WITH PROSTATE CANCER-SPECIFIC MORTALITY AMONG BLACK AND WHITE MEN IN A CONTEMPORARY NORTH AMERICAN POPULATION
19. DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA
20. A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies
21. EVALUATING THE IMPACT OF LYMPOVASCULAR INVASION ON SURVIVAL OF SURGICALLY TREATED PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA: A NATIONWIDE ANALYSIS
22. Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis
23. Comparison of patient background between a real‐world North American cohort and the Göteborg‐2 trial.
24. Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA‐repair genes
25. MP55-04 THE PREOPERATIVE USE OF MICROUS TO DETECT EXTRAPROSTATIC EXTENSION OF PROSTATE CANCER: AN UPDATE OF A SINGLE INSTITUTIONAL PROSPECTIVE SERIES
26. MP55-03 CORRELATION BETWEEN PSMA PET/CT DATA AND PATHOLOGICAL TUMOUR STAGING AND GRADING OF PROSTATE CANCER
27. PD10-05 DEVELOPMENT OF A MICROULTRASOUND-BASED NOMOGRAM TO PREDICT EXTRACAPSULAR EXTENSION IN PATIENTS WITH PROSTATE CANCER UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY
28. MP55-15 IS MICROULTRASOUND A RELIABLE TOOL FOR PROSTATE CANCER DIAGNOSIS? RESULTS FROM A SINGLE-INSTITUTION COHORT OF OVER 1,000 MEN
29. Awareness of genetic risk for prostate cancer (PCa) in men from families with germline mutations in DNA-repair genes.
30. MP51-12 THE ADDED VALUE OF MICROUS FOR THE PREOPERATIVE STAGING OF PROSTATE CANCER: AN UPDATE OF A SINGLE-INSTITUTIONAL PROSPECTIVE SERIES
31. MP58-15 ASSESSING THE ROLE OF HIGH-RESOLUTION MICRO-ULTRASOUND AMONG PATIENTS WITH A NEGATIVE MULTIPARAMETRIC MRI AND A PERSISTENT SUSPICION OF PROSTATE CANCER
32. MP24-17 PROSPECTIVE VALIDATION AND COMPARISON OF DIFFERENT SCORING SYSTEMS FOR THE PREDICTION OF SURGICAL OUTCOME OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY
33. PD11-07 AWARENESS OF RISK OF PROSTATE CANCER (PCA) REMAINS POOR IN FAMILIES WITH GERMLINE MUTATIONS IN DNA-REPAIR GENES
34. MP54-13 THE UPDATE FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT FOR LOW-GRADE BLADDER TUMORS: LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS UNDER ACTIVE SURVEILLANCE
35. MP34-01 IS TESTIS SPARING SURGERY A SAFE APPROACH IN PATIENTS WITH SMALL TESTICULAR LESIONS REFERRING TO A FERTILITY CENTER? A RETROSPECTIVE ANALYSIS REPORTING LONG-TERM ONCOLOGICAL OUTCOMES AND FACTORS ASSOCIATED WITH MALIGNANCY
36. Processo costituzionale e teoria della interpretazione
37. Udienza 6 aprile 1937; Pres. Piga P., Est. Caccavale; Gabbiati c. Giuliani
38. Udienza 27 febbraio 1939; Pret. Cenciarini; Bergero (Avv. Barolo) c. Marchese (Avv. Boetti)
39. The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort
40. Midlife baseline prostate‐specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality.
41. IS TESTIS SPARING SURGERY A SAFE APPROACH IN PATIENTS WITH SMALL TESTICULAR LESIONS REFERRING TO A FERTILITY CENTER? A RETROSPECTIVE ANALYSIS REPORTING LONG-TERM ONCOLOGICAL OUTCOMES AND FACTORS ASSOCIATED WITH MALIGNANCY
42. PROSPECTIVE VALIDATION AND COMPARISON OF DIFFERENT SCORING SYSTEMS FOR THE PREDICTION OF SURGICAL OUTCOME OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY
43. THE ADDED VALUE OF MICROUS FOR THE PREOPERATIVE STAGING OF PROSTATE CANCER: AN UPDATE OF A SINGLE-INSTITUTIONAL PROSPECTIVE SERIES
44. AWARENESS OF RISK OF PROSTATE CANCER (PCA) REMAINS POOR IN FAMILIES WITH GERMLINE MUTATIONS IN DNA-REPAIR GENES
45. THE UPDATE FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT FOR LOW-GRADE BLADDER TUMORS: LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS UNDER ACTIVE SURVEILLANCE
46. ASSESSING THE ROLE OF HIGH-RESOLUTION MICRO-ULTRASOUND AMONG PATIENTS WITH A NEGATIVE MULTIPARAMETRIC MRI AND A PERSISTENT SUSPICION OF PROSTATE CANCER
47. Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohorts.
48. Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort Analysis.
49. Radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer: Analysis of an other-cause mortality matched cohort.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.